Navigation Links
Yongye Biotechnology International, Inc. Appoints New Independent Auditor
Date:7/10/2008

BEIJING, July 10 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology International, Inc. ("Yongye" or the "Company") (OTC Bulletin Board: YGYB), a leading distributor of plant and animal nutrients headquartered in Beijing, PRC, announced today it has engaged MSPC Certified Public Accountants and Advisors, P.C. as the Company's independent auditor.

The Company has engaged MSPC Certified Public Accountants and Advisors, P.C. ("MSPC") to serve as the Company's independent auditor effective immediately. MSPC was founded in 1944 and provides traditional accounting services to a wide range of companies, from emerging entrepreneurial ventures to large, publicly held entities. MSPC is an active member in Moore Stephens North America and Moore Stephens International Limited, a network of leading, independently owned and operated accounting and consulting firms. MSPC enjoys wide representation in all metropolitan areas in the United States as well as worldwide. MSPC is regarded as one of the world's top twenty accounting and consulting networks with more than 316 independently owned and operated member firms. There are 539 offices in 93 countries throughout the world including Hong Kong and China. It has 15,404 principals and staff.

About Yongye Biotechnology, Inc.

Yongye Biotechnology International, Inc., headquartered in Beijing, is engaged in the domestic distribution and sales of fulvic acid based nutritional compounds for plants and animals. The Company's patent pending process and proprietary formulas allow it to create products which increase the yields in crop production and improve livestock health. The Company sells its products to distributors and farmers located in ten provinces across China including: Xinjiang, Hebei, Inner Mongolia, Gansu, Hubei, Shandong, Anhui, Jiangsu, Yunan, and Guangdong.

FORWARD-LOOKING STATEMENTS

Certain statements set forth in this press release constitute "Forward- looking statements" within t
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
2. Genetic Engineering & Biotechnology News reports on novel hit-to-lead drug discovery
3. Dietitian Mary Lee Chin Comments on Proven Value and Safety of Food Biotechnology in New Online Video
4. N.C. Biotechnology Center Launches Industrial Fellowship Program
5. Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs
6. In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study
7. Pharsight to Present on Literature-Based Disease Modeling Approaches at AAPS National Biotechnology Conference
8. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
9. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
10. Gen-Probe to Webcast Presentation at Seventh Annual Needham Biotechnology and Medical Technology Conference
11. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ENHAGEN, Dec. 2 The world,s first ...e technology, a breakthrough alternative to replac...ufacture of synthetic rubber with renewable biomas...eek. One tire will be on display at a lounge in th...ional Airport throughout December 21, while the ot...
(Date:12/2/2009)... LELYSTAD, The Netherlands, December 2 /PRNewswire...technology company focusing on protein mimicking,t...s today announced that it,has appointed Wim E.M. M... Dr. Mol will be responsible for all of Pepscans...d strategic direction of the company. He brings to...
(Date:12/2/2009)... RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/...ompany") (OTC Bulletin Board: EMDY), a leading,pro...mula, milk powder and,soybean products in China, t...n the Spring issue of US Food & Drink Executiv...250,000 executives in the food and beverage indust...
(Date:12/2/2009)... The Scientist, a leading scientific maga...cs’ Evolve “Intelligent” EMCCD c...Top 10 Innovations of 2009. , ...e; EMCCD camera from Photometrics ®, a desig...MCCD cameras for the life sciences, was ranked fou...
Breaking Biology Technology:The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Dutch Biotech Company Pepscan Appoints New CEO 2Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3
...USALEM and NEEDHAM, Massachusetts, December 10 /PR...wiss Exchange: ORIDN) today announced that,three s...be presented at the,upcoming AARC (American Associ...alifornia. These studies confirm the clinical bene...dion Microstream(R) capnography technology,and cle...
...SANNE, Switzerland, December 10 Diagnoplex, a,dev...nced the closing of a,Series A financing raising C...y Novartis Venture Fund and NeoMed, with Initiativ...rtis Venture Fund was also a seed investor in the,...stors and BMP Associés,acted as counsel to the co...
...MOUTH, Minn., Dec. 9 ev3 Inc. (Nasdaq: EVVV ),a...ay that it has received,510(k) clearance from the ...t its,EverCross 0.035" and NanoCross 0.014" periph...o begin full commercialization of the EverCross an...in January 2009. , Robert Palmisano, ev3,s presi...
Other Biology Technology:Oridion Announces Significant Medical Research to be Presented at AARC Congress 2Oridion Announces Significant Medical Research to be Presented at AARC Congress 3Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing 2Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing 3ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons 2ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons 3
(Date:12/2/2009)...tudy results strengthen the evidence that people w...e an increased risk for developing colorectal canc..., "This provides one more reason not to smoke, o... Michael J. Thun, M.D., M.S., vice president emeri... American Cancer Society. "Colorectal cancer shoul...
(Date:12/2/2009)...ce of a cancer-free status did not prompt people p...y (CT) lung-cancer screening program to pick up th... published in Cancer Epidemiology, Biomarkers & P...for Cancer Research. The December issue contains a...ld negate widespread concern in the lung screening...
(Date:12/2/2009)...iversity Medical Center researchers have figured o...ioma may be better able to resist radiation therap...g pathway in these cancer stem cells, they were ab...n a laboratory experiment. , The work builds of...ells resist the effects of radiation much better t...
Breaking Biology News(10 mins):Cigarette smoking increases colorectal cancer risk 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Discovery makes brain tumor cells more responsive to radiation 2Certain Arthritis Crohns Drugs May Raise Kids Cancer Risk 3A FDA 53660 1Certain Arthritis Crohns Drugs May Raise Kids Cancer Risk 3A FDA 53660 2Certain Arthritis Crohns Drugs May Raise Kids Cancer Risk 3A FDA 53660 3Silenced genes as a warning sign of blood cancer 53655 1Silenced genes as a warning sign of blood cancer 53655 2Nanotechnology Transforms Pain Relief 53652 1Nanotechnology Transforms Pain Relief 53652 2Nanotechnology Transforms Pain Relief 53652 3Nanotechnology Transforms Pain Relief 53652 4
...om The Wistar Institute in Philadelphia and The Vi...mechanism involved in normal repression of the p53...le for the control of cancer in humans. , The new... intriguing approaches to diagnosing or intervenin...port on the team,s findings will be published onli...
...ervational study by researchers at the University ...n between 65 and 80 years of age who received trea...ived significantly longer than men who did not rec... December 13th issue of the Journal of the America...revention education and the resulting wide-spread ...
...mazing protein-making parts out of cells and putti...eins for a wide variety of medical uses. At the an...) Sept. 13 in San Francisco, Stanford engineering ...ch "cell-free" protein synthesis, including produc...n act as delivery trucks for a new class of potent...
Other Biology News:Novel regulatory mechanism identified for key tumor suppressor p53 2Novel regulatory mechanism identified for key tumor suppressor p53 3Older men treated for early prostate cancer live longer than those who are not 2Engineer ramps up protein production, develops versatile viral spheres 2Engineer ramps up protein production, develops versatile viral spheres 3
Goat Anti-Human Contactin-2 Polyclonal Antibodies, from R&D Systems
Human BMP 2 ELISA construction Kit from Antigenix America Inc.
... 120 utilizies CTI Molecular Imaging's proprietary... retaining the same imaging volume as the R4. The... of any commerically avaiable PET scanner. Focus ...on of any scinitallor based PETsystems. The combi...
...duct has been developed to significantly increase ...ins. Stability is increased at room temperature s...This product is subjected to 0.45 micron filtratio...tion insures consistently high levels of activity ...
Biology Products: